It’s long-term, well it’s for life basically: Understanding and exploring the burden of immunoglobulin treatment in patients with primary immunodeficiency disorders
This paper describes the burden of receiving immunoglobulin (Ig) treatment from the perspective of patients diagnosed with a Primary Immunodeficiency (PID). Thirty semi-structured interviews with patients receiving intravenous (n=21) and subcutaneous immunoglobulin (n=9) therapy, either at home or...
Main Authors: | Georgina Jones, Eva Brown Hajdukova, Esmee Hanna, Rosie Duncan, Brendan Gough, Jane Hughes, Debbie Hughes, Fran Ashworth, Johan Prevot, Jose Drabwell, Leire Solis, Nizar Mahlaoui, Anna Shrimpton |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2021-02-01
|
Series: | Qualitative Research in Medicine & Healthcare |
Subjects: | |
Online Access: | https://pagepressjournals.org/index.php/qrmh/article/view/9564 |
Similar Items
-
The Development of a New Questionnaire to Measure the Burden of Immunoglobulin Treatment in Patients with Primary Immunodeficiencies: The IgBoT-35
by: Jones GL, et al.
Published: (2020-09-01) -
What Is the Burden of Immunoglobulin Replacement Therapy in Adult Patients With Primary Immunodeficiencies? A Systematic Review
by: Georgina L. Jones, et al.
Published: (2018-07-01) -
Is It Safe to Switch From Intravenous Immunoglobulin to Subcutaneous Immunoglobulin in Patients With Common Variable Immunodeficiency and Autoimmune Thrombocytopenia?
by: Philipp Scheuerlein, et al.
Published: (2018-07-01) -
Exercise and Immunodeficiency Affect Immunoglobulins in Endurance Horses
by: Krick, Kari Elizabeth
Published: (2014) -
Hyaluronidase facilitated subcutaneous immunoglobulin in primary immunodeficiency
by: Jolles S
Published: (2013-09-01)